Back to search
Myositis, Inclusion Body
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Myositis, Inclusion Body trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Myositis, Inclusion Body trials you may qualify forThis study will evaluate subjects with adult- and childhood-onset myositis to learn more about their cause and the immune system changes and medical problems as…
This single-arm pilot study evaluates the effects of whole-body electrical muscle stimulation (WB-EMS) exercise on neuromuscular and physical function in adults…
Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not…
To evaluate the efficacy of Pozelimab/Cemdisiran combination therapy in patients with sIBM
Refer to the "Detailed Description" section.
This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially…
Background: * Myositis is a rare disease in which the body s immune cells attack the muscle tissue. It can cause muscle weakness, swelling, and pain. It can de…
The goal of this observational study is to understand how diet may influence the disease characteristics of inclusion body myositis (IBM). Research findings wil…